Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
Hauptverfasser: | Antoniades, C, Demosthenous, M, Reilly, S, Margaritis, M, Jayaram, R, Nahar, K, Tousoulis, D, Stefanadis, C, Channon, K, Casadei, B |
---|---|
Format: | Journal article |
Veröffentlicht: |
2011
|
Ähnliche Einträge
Ähnliche Einträge
-
Myocardial superoxide and peroxynitrite as strong independent predictors of paroxysmal atrial fibrillation post-CABG
von: Demosthenous, M, et al.
Veröffentlicht: (2011) -
MYOCARDIAL SUPEROXIDE AND PEROXYNITRITE GENERATION PREDICT POST-OPERATIVE CLINICAL OUTCOME IN PATIENTS UNDERGOING ELECTIVE CABG
von: Antoniades, C, et al.
Veröffentlicht: (2011) -
Short-term preoperative treatment with atorvastatin improves myocardial redox state in patients undergoing elective CABG by affecting NADPH oxidase activity and NOS coupling
von: Antoniades, C, et al.
Veröffentlicht: (2010) -
Atorvastatin Treatment for Three Days Before CABG Improves Myocardial Redox State, by Modifying NADPH-Oxidase Activity and NOS Coupling
von: Demosthenous, M, et al.
Veröffentlicht: (2010) -
Systemic Lipid Peroxydation and Myocardial Superoxide/Peroxynitrite Anions as Predictors of Post-Operative Outcome in Cardiac Surgery
von: Margaritis, M, et al.
Veröffentlicht: (2011)